Wang D L, Wung B S, Shyy Y J, Lin C F, Chao Y J, Usami S, Chien S
Cardiovascular Division, Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, ROC.
Circ Res. 1995 Aug;77(2):294-302. doi: 10.1161/01.res.77.2.294.
Monocyte chemotactic protein-1 (MCP-1), a potent monocyte chemoattractant secreted by endothelial cells (ECs), is believed to play a key role in the early events of atherogenesis. Since vascular ECs are constantly subjected to mechanical stresses, we examined how cyclic strain affects the expression of the MCP-1 gene in human ECs grown on a flexible membrane base deformed by sinusoidal negative pressure (peak level, -16 kPa at 60 cycles per minute). Northern blot analysis demonstrated that the MCP-1 mRNA levels in ECs subjected to strain for 1, 5, or 24 hours were double those in control ECs (P < .05). This strain-induced increase was mainly serum independent, and MCP-1 mRNA level returned to its control basal level 3 hours after release of strain. Culture media from strained ECs contained approximately twice the MCP-1 concentration and more than twice the monocyte chemotactic activity of media from control ECs (P < .05). Pretreatment of collected media with anti-MCP-1 antibody suppressed such activity. Monocyte adhesion to ECs subjected to strain for 12 hours was 1.8-fold greater than adhesion to unstrained control ECs (P < .05). A protein kinase C inhibitor, calphostin C, abolished the strain-induced MCP-1 gene expression. In addition, cAMP- or cGMP-dependent protein kinase inhibitors (KT5720 and KT5823, respectively) partially inhibited such expression. Pretreatment with EGTA or the intracellular Ca2+ chelator BAPTA/AM strongly suppressed the strain-induced MCP-1 mRNA. Verapamil, a Ca2+ channel blocker, greatly reduced MCP-1 mRNA levels in both strained and unstrained ECs.(ABSTRACT TRUNCATED AT 250 WORDS)
单核细胞趋化蛋白-1(MCP-1)是一种由内皮细胞(ECs)分泌的强效单核细胞趋化剂,被认为在动脉粥样硬化发生的早期事件中起关键作用。由于血管内皮细胞不断受到机械应力作用,我们研究了循环应变如何影响在由正弦负压(峰值水平,每分钟60次循环时为-16 kPa)变形的柔性膜基质上生长的人内皮细胞中MCP-1基因的表达。Northern印迹分析表明,经受1、5或24小时应变的内皮细胞中MCP-1 mRNA水平是对照内皮细胞中的两倍(P <.05)。这种应变诱导的增加主要不依赖于血清,并且在应变释放后3小时,MCP-1 mRNA水平恢复到其对照基础水平。来自经受应变的内皮细胞的培养基中MCP-1浓度约为对照内皮细胞培养基的两倍,单核细胞趋化活性则超过两倍(P <.05)。用抗MCP-1抗体预处理收集的培养基可抑制这种活性。与未受应变的对照内皮细胞相比,经受12小时应变的内皮细胞上单核细胞的黏附增加了1.8倍(P <.05)。蛋白激酶C抑制剂钙泊三醇C消除了应变诱导的MCP-1基因表达。此外,cAMP或cGMP依赖性蛋白激酶抑制剂(分别为KT5720和KT5823)部分抑制了这种表达。用EGTA或细胞内Ca2+螯合剂BAPTA/AM预处理可强烈抑制应变诱导的MCP-1 mRNA。钙通道阻滞剂维拉帕米大大降低了受应变和未受应变的内皮细胞中的MCP-1 mRNA水平。(摘要截短于250字)